Consistently, transwell invasion assays indicated that over-expression of IGSF9 led to a significant decrease of cell invasion ability, while IGSF9 knockdown resulted in an increase of cell invasion in breast cancer cells (Figs. S5G and 3F, J). This evidence concerns the gene IGSF9 and breast carcinoma.